Recall archive / FDA drug enforcement
C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, ... — FDA record D-0538-2023
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Apr 13, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402
- Reason
- Lack of assurance of sterility.
- Classification
- Class II
- Recalling firm
- Pharmacy Plus, Inc. dba Vital Care Compounder
- Quantity
- 45 vials
- Agency-reported status
- Ongoing
- Source record identifier
- D-0538-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: 73810, Exp. Date 5/1/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
MS only
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Apr 26, 2023
- Recall initiation date
- Apr 13, 2023
- Center classification date
- Apr 19, 2023
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.